Edition:
United States

Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

377.46USD
4:02pm EDT
Change (% chg)

$-7.67 (-1.99%)
Prev Close
$385.13
Open
$386.00
Day's High
$386.00
Day's Low
$377.45
Volume
50
Avg. Vol
858
52-wk High
$389.10
52-wk Low
$276.42

Select another date:

Mon, May 15 2017

BRIEF-Greenlight Capital takes share stake in Alere, Micron Technology

* Greenlight Capital Inc takes share stake of 1.0 million shares in Alere Inc

BRIEF-Alere Inc files for non-timely 10-Q

* Alere Inc says does not anticipate significant changes in results of operations for quarter ended march 31, 2017 versus quarter ended march 31, 2016

BRIEF-Alere Inc modifies consent solicitations for notes

* Alere Inc. Announces modifications of consent solicitations for Alere Inc.'s notes

BRIEF-Alere reports commencement of consent solicitations for notes

* Alere Inc. Announces commencement of consent solicitations for alere inc.'s notes

BRIEF-Alere launches the first-ever rapid test to screen malaria infection in asymptomatic individuals

* Alere launches the Alere malaria AG P.F, the first-ever rapid test to screen malaria infection in asymptomatic individuals Source text for Eikon: Further company coverage:

BRIEF-Alere Inc enters into third amendment

* Alere Inc - on April 24, co entered into third amendment, dated as of April 24, to secured credit agreement, dated as of June 18, 2015

Abbott sees Alere as challenging 'fixer-upper' after revised deal

Abbott Laboratories said it was looking to close the recently revised deal to buy Alere Inc in the coming months, calling the diagnostics company "a bit of a fixer-upper".

UPDATE 3-Abbott sees Alere as challenging "fixer-upper" after revised deal

* Closing of new Alere deal is a little unpredictable - CFO (Adds conference call details; Updates shares)

BRIEF-Abbott CFO says "We're not going to really be in a good position to give a lot of detailed guidance (on Alere) until minimum Q4" - Conf Call

* Abbott CEO says "the acquisition of Alere will significantly expand our diagnostics presence and leadership in that space" - Conf Call

BRIEF-Alere concluded its financial statements as of Dec 31, 2015 and 2014 should not be relied upon

* Alere - On April 12, concluded co's financial statements and other financial data as of December 31, 2015 and 2014 should not be relied upon - SEC filing

Select another date:

More From Around the Web